Quadrature Capital LTD Fulgent Genetics, Inc. Transaction History

Quadrature Capital LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $554,182 - $1.07 Million	-11,117 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $480,728 - $652,995	6,219 Added 126.97%	11,117 $1.12 Million
Q3 2021 Nov 15, 2021	SELL	$74.87 - $110.87 $2.44 Million - $3.61 Million	-32,567 Reduced 86.93%	4,898 $441,000
Q2 2021 Aug 16, 2021	BUY	$66.8 - $100.45 $2.5 Million - $3.76 Million	37,465 New	37,465 $3.46 Million

199

14.7M

1.16M

92.9K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $605M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Quadrature Capital LTD with notifications on news.